Patient Guide: A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 22 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07157254
Status: 🟢 Enrolling Now
Condition: Angelman Syndrome
Phase: PHASE2

Where You Can Participate

This study is available at 22 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Chicago, Illinois
  • • Baltimore, Maryland
  • • And 19 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) - Join Clinical Trial NCTNCT07157254

How to Join This Clinical Trial - NCTNCT07157254

Learn how to participate in this PHASE2 trial studying an investigational therapy for Angelman Syndrome. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Angelman Syndrome. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Angelman Syndrome
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07157254 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 22 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90048 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baltimore, Maryland 21205 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Kansas City, Missouri 64108 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hillsborough, North Carolina 27278 - United States

Status: RECRUITING

Clinical Research Site

Akron, Ohio 44308 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Austin, Texas 78723 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Dallas, Texas 75243 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Pilar, Buenos Aires - Argentina

Status: NOT_YET_RECRUITING

And 12 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Angelman Syndrome:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships